PolyPeptide Group AG

PolyPeptide Group AG

Share · CH1110760852 (XSWX)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PolyPeptide Group AG
No Price
Closing Price XSWX 29.04.2026: 35,50 CHF
29.04.2026 07:11
Current Prices from PolyPeptide Group AG
ExchangeTickerCurrencyLast TradePriceDaily Change
XSWX: SIX
SIX
PPGN.SW
CHF
29.04.2026 07:11
35,50 CHF
0,20 CHF
+0,57 %
XLON: London
London
0AAJ.L
CHF
29.04.2026 07:10
35,45 CHF
0,15 CHF
+0,43 %
XDQU: Quotrix
Quotrix
PPGAGN52.DUSD
EUR
29.04.2026 05:27
38,20 EUR
-3,40 EUR
-8,17 %
XDUS: Düsseldorf
Düsseldorf
PPGAGN52.DUSB
EUR
28.04.2026 17:30
37,90 EUR
-3,70 EUR
-8,89 %
Share Float & Liquidity
Free Float 39,26 %
Shares Float 12,96 M
Shares Outstanding 33,01 M
Company Profile for PolyPeptide Group AG Share
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

Company Data

Name PolyPeptide Group AG
Company PolyPeptide Group AG
Website https://www.polypeptide.com
Primary Exchange XSWX SIX
ISIN CH1110760852
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Juan Jose Gonzalez
Market Capitalization 1 Mrd.
Country Switzerland
Currency CHF
Employees 1,4 T
Address Dammstrasse 19, 6300 Baar
IPO Date 2021-04-28
Dividends from 'PolyPeptide Group AG'
Ex-Date Dividend per Share
28.04.2022 0,30 CHF

Ticker Symbols

Name Symbol
Düsseldorf PPGAGN52.DUSB
Frankfurt 8H0.F
London 0AAJ.L
Quotrix PPGAGN52.DUSD
SIX PPGN.SW
More Shares
Investors who hold PolyPeptide Group AG also have the following shares in their portfolio:
First Tractor Company Limited
First Tractor Company Limited Share
i(x) Net Zero Plc
i(x) Net Zero Plc Share